INISInternational Isotopes, Inc.

About International Isotopes, Inc. (INIS)

International Isotopes, Inc. (INIS) is a Drug Manufacturers - Specialty & Generic company headquartered in Idaho Falls, ID, United States whose shares trade over-the-counter on the OTCQB tier.

Our mission is to provide high quality products and services as a profitable and environmentally conscious business while providing unsurpassed customer service and a safe and rewarding working environment for our employees.

Products and services

INIS and its subsidiaries, TI Services and RadQual, manufacture a full range of nuclear medicine calibration and reference standards, generic sodium iodide I-131 drug product, cobalt teletherapy sources, and medical devices for medical research, and clinical applications.

INIS key facts

Ticker symbol

INIS

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Idaho Falls, ID, United States

Country of incorporation

US

Year of incorporation

1995

Employees

38

Estimated market cap

$23.61M (as of Apr 11, 2025)

Shares outstanding

524,950,080

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

International Isotopes, Inc. leadership

• Shahe Alex Bagerdjian — CEO, President
• William M Cox — CFO, Corporate Secretary
• David Drewitz — IR

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with I